X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-13 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $1.38 | -7,086 | 569,345 | -1% | -$9,757 | ||||||
2023-06-13 | NVTA | Brida Thomas | See Remarks | S - Sale | $1.38 | -7,079 | 704,087 | -1% | -$9,748 | ||||||
A | 2023-05-16 | NVTA | Wen Yafei | CFO | S - Sale | $1.20 | -43,452 | 700,297 | -6% | -$52,112 | |||||
2023-05-16 | NVTA | Knight Kenneth D. | CEO | S - Sale | $1.20 | -45,432 | 1,671,610 | -3% | -$54,487 | ||||||
2023-05-16 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $1.20 | -26,476 | 576,431 | -4% | -$31,753 | ||||||
2023-05-16 | NVTA | Wen Yafei | CFO | S - Sale | $1.99 | -43,452 | 700,297 | -6% | -$86,600 | ||||||
2023-05-16 | NVTA | Werner Robert F. | Chief Accounting Officer | S - Sale | $1.20 | -21,559 | 354,748 | -6% | -$25,856 | ||||||
2023-05-16 | NVTA | Brida Thomas | See Remarks | S - Sale | $1.20 | -26,476 | 711,166 | -4% | -$31,753 | ||||||
2023-03-13 | NVTA | Brida Thomas | See Remarks | S - Sale | $1.41 | -2,625 | 437,642 | -1% | -$3,701 | ||||||
2023-03-13 | NVTA | Nussbaum Robert L | Chief Medical Officer | S - Sale | $1.41 | -2,625 | 447,907 | -1% | -$3,701 | ||||||
2023-03-13 | NVTA | Wen Yafei | CFO | S - Sale | $1.41 | -2,625 | 443,749 | -1% | -$3,701 | ||||||
2023-03-13 | NVTA | Knight Kenneth D. | CEO | S - Sale | $1.41 | -1,853 | 517,042 | 0% | -$2,613 | ||||||
M | 2022-12-16 | NVTA | George Sean E | Dir | S - Sale | $2.05 | -55,979 | 732,677 | -7% | -$114,630 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |